Proficio Capital Partners LLC Invests $95,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Proficio Capital Partners LLC purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 94,504 shares of the medical device company’s stock, valued at approximately $95,000.

Other hedge funds have also recently modified their holdings of the company. Victory Capital Management Inc. raised its stake in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after purchasing an additional 574,899 shares during the period. Torray Investment Partners LLC lifted its stake in shares of Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares during the period. Charles Schwab Investment Management Inc. grew its position in Cooper Companies by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,151,654 shares of the medical device company’s stock worth $105,872,000 after buying an additional 35,035 shares during the last quarter. Steward Partners Investment Advisory LLC grew its position in Cooper Companies by 19.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company’s stock worth $129,000 after purchasing an additional 226 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its holdings in shares of Cooper Companies by 227.7% during the 4th quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company’s stock valued at $89,000 after acquiring an additional 674 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COO has been the topic of several research analyst reports. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Stifel Nicolaus lowered their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Finally, Citigroup dropped their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Performance

Shares of COO stock opened at $83.77 on Friday. The business’s 50 day simple moving average is $89.33 and its 200 day simple moving average is $97.36. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The stock has a market capitalization of $16.75 billion, a PE ratio of 42.96, a PEG ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.